Blog
RSS FeedPosted by Michael Wonder on 04 Sep 2019
Forty Seven granted fast track designation for magrolimab for the treatment of myelodysplastic syndrome and acute myeloid leukaemia
3 September 2019 - Forty Seven today announced that the U.S. FDA has granted fast track designation to magrolimab (formerly known ...
Posted by Michael Wonder on 04 Sep 2019
Inotrem announces fast track designation granted by U.S. FDA to nangibotide development program for the treatment of septic shock
4 September 2019 - Inotrem announced today that the U.S. FDA has granted fast track designation to nangibotide development program for ...
Posted by Michael Wonder on 29 Aug 2019
Zensun announces the investigation of Neucardin for chronic heart failure receives fast track designation from the US FDA
26 August 2019 - Zensun announced that the investigation of Neucardin, its recombinant human neuregulin-1 fragment, has received fast track designation ...
Posted by Michael Wonder on 29 Aug 2019
Emalex Biosciences receives FDA fast track designation for ecopipam for the treatment of patients with Tourette syndrome
28 August 2019 - Emalex Biosciences announced today that it has received fast track designation for its investigational product, ecopipam, from ...
Posted by Michael Wonder on 27 Aug 2019
DiscGenics receives FDA fast track designation for disc degeneration cell therapy
26 August 2019 - DiscGenics today announced that the U.S. FDA has granted Fast Track designation for its investigational cell ...
Posted by Michael Wonder on 27 Aug 2019
FDA grants fast track designation for Farxiga in chronic kidney disease
27 August 2019 - AstraZeneca today announced that the US FDA has granted fast track designation for the development of ...
Posted by Michael Wonder on 25 Aug 2019
Medipost’s Pneumostem gets FDA’s fast-track designation
23 August 2019 - Medipost said that the U.S. FDA has given a fast- track designation for Pneumostem, a bronchopulmonary ...
Posted by Michael Wonder on 21 Aug 2019
Cerecor receives fast track designation from FDA for CERC-802 for the treatment of mannose-phosphate isomerase deficiency
21 August 2019 - Cerecor announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for ...
Posted by Michael Wonder on 20 Aug 2019
Moderna receives FDA fast track designation for Zika vaccine mRNA-1893
19 August 2019 - Moderna today announced that the U.S. FDA has granted fast track designation for its investigational Zika vaccine ...
Posted by Michael Wonder on 14 Aug 2019
Akari Therapeutics receives FDA fast track designation for nomacopan for paediatric haematopoietic stem cell transplant-related thrombotic microangiopathy
14 August 2019 - Proposed pivotal trial of nomacopan in paediatric patients with HSCT-TMA expected to start Q4 2019 in North ...
Posted by Michael Wonder on 13 Aug 2019
Windtree announces FDA fast track designation for istaroxime
13 August 2019 - Fast track designation highlights the potential for istaroxime to address unmet medical needs of patients hospitalised with ...
Posted by Michael Wonder on 31 Jul 2019
Momenta Pharmaceuticals announces fast track designation for M281 (nipocalimab) in haemolytic disease of the foetus and newborn
30 July 2019 - Momenta Pharmaceuticals today announced that the U.S. FDA has granted fast track designation for M281, Momenta’s ...
Posted by Michael Wonder on 30 Jul 2019
NeuroVive’s NeuroSTAT project receives FDA fast track designation
27 July 2019 - NeuroVive Pharmaceutical today announced that the company’s candidate drug NeuroSTAT, in development for treatment of moderate ...
Posted by Michael Wonder on 26 Jul 2019
Matinas BioPharma receives qualified infectious disease product and fast track designations from U.S. FDA for MAT2203 for the treatment of cryptococcal meningitis
25 July 2019 - Fourth QIDP and fast track designations granted by FDA for MAT2203. ...
Posted by Michael Wonder on 10 Jul 2019
Cellectar receives FDA fast track designation for CLR 131 in diffuse large B-cell lymphoma
9 July 2019 - Cellectar Biosciences today announced the U.S. FDA has granted fast track designation for CLR 131 in relapsed ...